Tech Company Financing Transactions
Abrexa Pharmaceuticals Funding Round
Abrexa Pharmaceuticals, based in San Diego, raised $7.6 million from private investors.
Transaction Overview
Company Name
Announced On
8/9/2018
Transaction Type
Venture Equity
Amount
$7,632,252
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 7 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12481 High Bluff Dr. 150
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Email Address
Not Recorded
Overview
Abrexa Pharmaceuticals is a stealth mode pharmaceutical development company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lynne Rollins
Browse more venture capital transactions:
Prev: 8/9/2018: DNAlite Therapeutics venture capital transaction
Next: 8/9/2018: Dor venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs